Immunocellular
  • home
  •  
  • about
    • Overview
    • Our Team »
      • management
      • board of directors
      • scientific advisory board
      •  
    • Business Development
    •  
  •  
  • leadership in immunotherapy
    • Introduction To Immunotherapy
    • Getting To The Roots Of Cancer
    • Resources & Publications
    •  
  •  
  • pipeline & technologies
    • Active Immunotherapies
    • Monoclonal Antibodies
    • Pipeline Chart
    •  
  •  
  • newsroom
    • IMUC in the News
    •  
  •  
  • investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance »
      • Board of Directors
      • Committee Composition
      •  
    • Financial Information »
      • SEC Filings
      • Key Ratios
      •  
    • Stock Information »
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend Policy
      • Analyst Coverage
      • Ownership Profile
      •  
    • Shareholder Briefcase »
      • RSS Feeds
      • Mobile Investor
      • Snapshot
      • Downloads
      •  
    • Contact Us
    •  
  •  
  • contact us
    • General Inquiry
    • Investor Inquiry
    • Business Development
    • Media Inquiry
    •  
  • introduction to immunotherapy
  • getting to the roots of cancer
  • resources & publications

Resources & Publications

Please review the videos and articles related to immunotherapy, cancer treatments, and other related topics.

Scientific PublicationsVideos

  • Movie 1: Health Politics with Dr. Mike Magee
  • Movie 2: CBS - Treating Glioma

Articles

  • The Economist - A Strand Apart
  • Time - A Shot at Cancer
  • The New York Times - Screening Could Lead to More Potent Cancer Drugs
  • The Economist - The Root of All Evil?
  • The Economist - Stemming the Tumorous Tide
  • Nature Biotechnology - Drug makers chase cancer stem cells
  • Nature Biotechnology - The cancer vaccine roller coaster
  • NCI Cancer Bulletin - The Evolving Science of Cancer Stem Cells

Scientific Publications

  • Vaccination of Malignant Glioma Patients with Peptide-pulsed Dendritic Cells
  • HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells
  • Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma
  • Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapy
  • Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
  • Isolation of tumour stem-like cells from benign tumours
  • Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
  • The therapeutic promise of the cancer stem cell concept
  • Brain cancer vaccine looks promising in small trial
  • home
  • about
  • leadership in immunotherapy
  • pipeline & technologies
  • newsroom
  • investors
  • contact us
  • sitemap

21900 Burbank Blvd., 3rd Floor, Woodland Hills, CA 91367

    | (818) 992-2907 | | About this site